114 related articles for article (PubMed ID: 17709311)
21. Expression of thyroid transcription factor-1 in brain metastases: a useful indicator of pulmonary origin.
Chuang WY; Yeh CJ; Chu PH; Liao CC; Wu CT; Chuang CC; Pai PC; Tseng CK; Jung SM; Wei KC; Chang CN
J Clin Neurosci; 2008 Jun; 15(6):643-6. PubMed ID: 18413286
[TBL] [Abstract][Full Text] [Related]
22. The value of immunohistochemical expression of TTF-1, CK7 and CK20 in the diagnosis of primary and secondary lung carcinomas.
Al-Zahrani IH
Saudi Med J; 2008 Jul; 29(7):957-61. PubMed ID: 18626520
[TBL] [Abstract][Full Text] [Related]
23. Positive immunostaining for thyroid transcription factor-1 in primary and metastatic colonic adenocarcinoma: a note of caution.
Penman D; Downie I; Roberts F
J Clin Pathol; 2006 Jun; 59(6):663-4. PubMed ID: 16731609
[TBL] [Abstract][Full Text] [Related]
24. Unusual expression of thyroid transcription factor 1 and napsin A in metastatic adenoid cystic carcinoma of extrapulmonary origin in the lung.
An J; Park S; Sung SH; Cho MS; Kim SC
Am J Clin Pathol; 2014 May; 141(5):712-7. PubMed ID: 24713744
[TBL] [Abstract][Full Text] [Related]
25. Thyroid transcription factor-1 in primary CNS tumors.
Kristensen MH; Nielsen S; Vyberg M
Appl Immunohistochem Mol Morphol; 2011 Oct; 19(5):437-43. PubMed ID: 21325940
[TBL] [Abstract][Full Text] [Related]
26. Biomarker-assisted diagnosis of ovarian, cervical and pulmonary small cell carcinomas: the role of TTF-1, WT-1 and HPV analysis.
Carlson JW; Nucci MR; Brodsky J; Crum CP; Hirsch MS
Histopathology; 2007 Sep; 51(3):305-12. PubMed ID: 17727473
[TBL] [Abstract][Full Text] [Related]
27. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
[TBL] [Abstract][Full Text] [Related]
28. Thyroid transcription factor in differentiating type II cells: regulation, isoforms, and target genes.
Kolla V; Gonzales LW; Gonzales J; Wang P; Angampalli S; Feinstein SI; Ballard PL
Am J Respir Cell Mol Biol; 2007 Feb; 36(2):213-25. PubMed ID: 16960125
[TBL] [Abstract][Full Text] [Related]
29. Transcription expression and clinical significance of TTF-1 mRNA in pleural effusion of patients with lung cancer.
Jiang B; Wu GP; Zhao YJ; Wang SC
Diagn Cytopathol; 2008 Dec; 36(12):849-54. PubMed ID: 18855882
[TBL] [Abstract][Full Text] [Related]
30. Significant expression of thyroid transcription factor-1 in pulmonary squamous cell carcinoma detected by SPT24 monoclonal antibody and CSA-II system.
Kashima K; Hashimoto H; Nishida H; Arakane M; Yada N; Daa T; Yokoyama S
Appl Immunohistochem Mol Morphol; 2014; 22(2):119-24. PubMed ID: 23531851
[TBL] [Abstract][Full Text] [Related]
31. Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions.
Dejmek A; Naucler P; Smedjeback A; Kato H; Maeda M; Yashima K; Maeda J; Hirano T
Diagn Cytopathol; 2007 Aug; 35(8):493-7. PubMed ID: 17636482
[TBL] [Abstract][Full Text] [Related]
32. The Incidence of Labelling of Non-Lung Adenocarcinomas With Antibodies Against TTF-1 and Diagnostic Implications.
Prabhakaran S; Woo WLW; Xing G; Moffat D; Hussey M; Henderson DW; Klebe S
Appl Immunohistochem Mol Morphol; 2020 Jul; 28(6):471-476. PubMed ID: 31135446
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological and molecular implications of aberrant thyroid transcription factor-1 expression in colorectal carcinomas: an immunohistochemical analysis of 1319 cases using three different antibody clones.
Bae JM; Kim JH; Park JH; Park HE; Cho NY; Kang GH
Histopathology; 2018 Feb; 72(3):423-432. PubMed ID: 28914964
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic Utility of Thyroid Transcription Factor-1 in Ovarian Carcinoma and Its Relationship With Clinicopathologic Prognostic Parameters.
Hakim SA; Youssef NS
Appl Immunohistochem Mol Morphol; 2017 Apr; 25(4):237-243. PubMed ID: 26657873
[TBL] [Abstract][Full Text] [Related]
35. [Diagnostic value of the monoclonal antibody to thyroid transcription factor -1(TTF-1) in CNS metastases. An immunohistochemical study of 65 cases].
Romeike BF; Feiden W
Pathologe; 2002 Jul; 23(4):292-6. PubMed ID: 12185782
[TBL] [Abstract][Full Text] [Related]
36. Expression of thyroid transcription factor 1 in primary brain tumours.
Zamecnik J; Chanova M; Kodet R
J Clin Pathol; 2004 Oct; 57(10):1111-3. PubMed ID: 15452173
[TBL] [Abstract][Full Text] [Related]
37. Unexpected TTF-1 Positivity in a Subset of Gastric Adenocarcinomas.
Choi SM; Furth EE; Zhang PJ
Appl Immunohistochem Mol Morphol; 2016 Sep; 24(8):603-7. PubMed ID: 26469324
[TBL] [Abstract][Full Text] [Related]
38. Thyroid transcription factor-1 immunocytochemical staining of pleural fluid cytocentrifuge preparations for detection of small cell lung carcinoma.
Liu J; Farhood A
Acta Cytol; 2004; 48(5):635-40. PubMed ID: 15471255
[TBL] [Abstract][Full Text] [Related]
39. The correlation between TTF-1 immunoreactivity and the occurrence of lymph node metastases in patients with lung cancer.
Altaner S; Yoruk Y; Tokatli F; Koçak Z; Tosun B; Guresci S; Kutlu K
Tumori; 2006; 92(4):323-6. PubMed ID: 17036524
[TBL] [Abstract][Full Text] [Related]
40. Positivity for GATA3 and TTF-1 (SPT24), and Negativity for Monoclonal PAX8 Expand the Biomarker Profile of the Solid Cell Nests of the Thyroid Gland.
Gucer H; Mete O
Endocr Pathol; 2018 Mar; 29(1):49-58. PubMed ID: 29313264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
